Mesodermal expression of Fgfr2S252W is necessary and sufficient to induce craniosynostosis in a mouse model of Apert

Greg Holmes1, Claudio Basilico

  • 1Department of Microbiology, New York University School of Medicine, 550 1st Ave, New York, NY 10016, USA. gregory.holmes@exchange.mssm.edu

Insights

Craniosynostosis, or premature skull fusion, can result from genetic mutations. In Apert syndrome, a specific FGFR2 mutation causes craniosynostosis by inducing bone formation within the skull suture, not by cell mixing.

Area of Science:

  • Developmental biology
  • Genetics
  • Pediatric disease

Background:

  • Craniosynostosis is premature fusion of skull bones, affecting 1 in 2500 births.
  • Syndromic craniosynostosis often results from genetic mutations, including FGFRs and TWIST1.
  • Previous research in TWIST1 models showed cell mixing during suture fusion, but its role in FGFR-related craniosynostosis was unknown.

Purpose of the Study:

  • To investigate the mechanism of suture fusion in the Apert Fgfr2(S252W) mouse model.
  • To determine the role of cell lineage and migration in FGFR-mediated craniosynostosis.

Main Methods:

  • Utilized Cre/lox recombination to induce specific gene expression in neural crest or mesoderm.
  • Generated conditional mouse models for Apert syndrome (Fgfr2(S252W) mutation).
  • Analyzed skull development and suture fusion in mutant mice.

Main Results:

  • Mutation in the mesoderm alone was sufficient to cause craniosynostosis.
  • Mutation in the neural crest did not cause craniosynostosis.
  • Suture fusion occurred without disruption of the lineage border or aberrant cell migration; the suture mesenchyme underwent osteogenesis.
  • Ruled out roles for dura mater or skull base changes.

Conclusions:

  • FGFR2 mutations in Apert syndrome cause craniosynostosis through direct induction of osteogenesis in the suture mesenchyme.
  • Cellular lineage mixing is not the mechanism for suture fusion in this FGFR-mediated craniosynostosis model.
  • Conditional mutant mice enable further study of Apert syndrome post-natally.